SE441358B - Sett att framstella 2-substituerad-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido-(4,3-b)indoler - Google Patents

Sett att framstella 2-substituerad-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido-(4,3-b)indoler

Info

Publication number
SE441358B
SE441358B SE8000329A SE8000329A SE441358B SE 441358 B SE441358 B SE 441358B SE 8000329 A SE8000329 A SE 8000329A SE 8000329 A SE8000329 A SE 8000329A SE 441358 B SE441358 B SE 441358B
Authority
SE
Sweden
Prior art keywords
fluorophenyl
trans
hexahydro
solution
pyrido
Prior art date
Application number
SE8000329A
Other languages
English (en)
Swedish (sv)
Other versions
SE8000329L (sv
Inventor
Jr W M Welch
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE8000329L publication Critical patent/SE8000329L/xx
Publication of SE441358B publication Critical patent/SE441358B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/09—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/487—Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
SE8000329A 1979-01-23 1980-01-15 Sett att framstella 2-substituerad-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido-(4,3-b)indoler SE441358B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/005,698 US4224329A (en) 1979-01-23 1979-01-23 2-Substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles

Publications (2)

Publication Number Publication Date
SE8000329L SE8000329L (sv) 1980-07-24
SE441358B true SE441358B (sv) 1985-09-30

Family

ID=21717248

Family Applications (3)

Application Number Title Priority Date Filing Date
SE8000329A SE441358B (sv) 1979-01-23 1980-01-15 Sett att framstella 2-substituerad-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido-(4,3-b)indoler
SE8404554A SE8404554L (sv) 1979-01-23 1984-09-11 Mellanprodukter for framstellning av 2-substituerade trans-5-aryl-2,3,4,4a,9b-hexahydro-1h-pyrido(4,3-b)indoler
SE8404555A SE8404555D0 (sv) 1979-01-23 1984-09-11 Mellanprodukter for framstellning av 2-substituerade trans-5-aryl-2,3,4,4a,9b-hexahydro-1h-pyrido(4,3-b)indoler

Family Applications After (2)

Application Number Title Priority Date Filing Date
SE8404554A SE8404554L (sv) 1979-01-23 1984-09-11 Mellanprodukter for framstellning av 2-substituerade trans-5-aryl-2,3,4,4a,9b-hexahydro-1h-pyrido(4,3-b)indoler
SE8404555A SE8404555D0 (sv) 1979-01-23 1984-09-11 Mellanprodukter for framstellning av 2-substituerade trans-5-aryl-2,3,4,4a,9b-hexahydro-1h-pyrido(4,3-b)indoler

Country Status (34)

Country Link
US (1) US4224329A (de)
JP (4) JPS55100386A (de)
KR (1) KR830001932A (de)
AR (1) AR231291A1 (de)
AT (1) AT376674B (de)
AU (1) AU521986B2 (de)
BE (1) BE881283A (de)
CA (1) CA1144168A (de)
CH (2) CH651040A5 (de)
CS (4) CS221808B2 (de)
DD (2) DD149071A5 (de)
DE (1) DE3002367A1 (de)
DK (1) DK25580A (de)
EG (1) EG14767A (de)
FI (1) FI800179A (de)
FR (3) FR2447379A1 (de)
GB (1) GB2041925B (de)
GR (1) GR73567B (de)
HU (3) HU189174B (de)
IE (1) IE49500B1 (de)
IL (1) IL59189A (de)
IN (1) IN153300B (de)
IT (1) IT1149927B (de)
LU (1) LU82105A1 (de)
NL (1) NL8000385A (de)
NO (2) NO151895C (de)
NZ (3) NZ192175A (de)
PH (4) PH15736A (de)
PL (4) PL126032B1 (de)
PT (1) PT70724A (de)
SE (3) SE441358B (de)
SU (3) SU1168094A3 (de)
YU (2) YU269379A (de)
ZA (1) ZA796374B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431649A (en) * 1979-07-30 1984-02-14 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4431646A (en) * 1979-07-30 1984-02-14 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4432978A (en) * 1979-07-30 1984-02-21 Pfizer Inc. Hexahydro-trans-pyridoindole
US4337250A (en) * 1979-07-30 1982-06-29 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4427679A (en) 1981-01-16 1984-01-24 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4467090A (en) * 1982-09-30 1984-08-21 Pfizer Inc. Compound, 8-fluoro-5-(p-fluorophenyl)-2-[4-(p-fluorophenyl)-4-hydroxybutyryl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole
US4477669A (en) * 1982-09-30 1984-10-16 Pfizer Inc. Processes and intermediates useful in the preparation of flutroline
US4451655A (en) * 1982-05-17 1984-05-29 Pfizer Inc. Process for preparing carboline derivatives and compounds used in their preparation
US4698444A (en) * 1982-09-30 1987-10-06 Pfizer Inc. 1,1-bis(p-fluorophenyl)urea
US4568748A (en) * 1982-09-30 1986-02-04 Pfizer Inc. 2-Carbobenzoxy-8-fluoro-5-(p-fluorophenyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole
JPS61248502A (ja) * 1985-04-26 1986-11-05 Pioneer Electronic Corp 磁性材料の接合方法
US4672117A (en) * 1985-09-16 1987-06-09 American Home Products Corporation Antipsychotic gamma-carbolines
US4636563A (en) * 1985-09-16 1987-01-13 American Home Products Corporation Antipsychotic γ-carbolines
US4798896A (en) * 1988-01-19 1989-01-17 American Home Products Corporation Antipsychotic gamma-carboline N-oxides
US5075315A (en) * 1990-05-17 1991-12-24 Mcneilab, Inc. Antipsychotic hexahydro-2H-indeno[1,2-c]pyridine derivatives
CA2355716C (en) * 1998-12-21 2010-05-18 Janssen Pharmaceutica N.V. Benzisoxazoles and phenones as .alpha.2-antagonists
RU2329044C1 (ru) * 2006-11-16 2008-07-20 Андрей Александрович Иващенко Лиганды 5-ht6 рецепторов, фармацевтическая композиция, способ ее получения и лекарственное средство

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA551241A (en) * 1958-01-07 S. Abbott Leslie Production of substituted piperidines
US3382250A (en) * 1966-12-07 1968-05-07 Abbott Lab Aroylalkyl derivatives of 1, 2, 3, 4-tetrahydro-5h-pyrido[4, 3b]indoles
US3687961A (en) * 1971-05-03 1972-08-29 Abbott Lab 8-fluoro-2-{8 3-(4-fluorophenylanilinopropyl{9 -gamma-carboline
AR205452A1 (es) * 1973-12-06 1976-05-07 Endo Lab Metodo para preparar nuevos trans-2, 3, 4, 4a, 5, 9b-hexahidro-5-fenil-1h-pirido(4,3-b) indoles
JPS50126699A (de) * 1974-03-20 1975-10-04
AR206812A1 (es) * 1974-04-01 1976-08-23 Pfizer Compuestos intermediarios de azaciclo(3,4-a)indoles 4- y 5-fenil substituidos desprovistos de actividad terapeutica
US4001263A (en) * 1974-04-01 1977-01-04 Pfizer Inc. 5-Aryl-1,2,3,4-tetrahydro-γ-carbolines
SE7702301L (sv) * 1976-04-08 1977-10-09 Endo Lab Trans-hexahydro-pyrido-indoler
SE441448B (sv) * 1977-05-23 1985-10-07 Pfizer Sett att framstella hexahydro-gamma-karbolinforeningar

Also Published As

Publication number Publication date
IT8019373A0 (it) 1980-01-22
DE3002367A1 (de) 1980-07-24
NZ197582A (en) 1984-05-31
JPS5636487A (en) 1981-04-09
GR73567B (de) 1984-03-16
SE8404554D0 (sv) 1984-09-11
YU269379A (en) 1984-04-30
FR2447379A1 (fr) 1980-08-22
PH15086A (en) 1982-07-02
NO151895B (no) 1985-03-18
CH651040A5 (fr) 1985-08-30
CS221808B2 (en) 1983-04-29
NZ197581A (en) 1984-05-31
CA1144168A (en) 1983-04-05
LU82105A1 (fr) 1980-08-08
AU5476580A (en) 1980-07-31
IL59189A (en) 1984-01-31
NO794317L (no) 1980-07-24
SU1080746A3 (ru) 1984-03-15
IT1149927B (it) 1986-12-10
IE49500B1 (en) 1985-10-16
SE8404555L (sv) 1984-09-11
EG14767A (en) 1985-12-31
PL126032B1 (en) 1983-07-30
CS221809B2 (en) 1983-04-29
PH15072A (en) 1982-06-03
ZA796374B (en) 1980-11-26
PH15736A (en) 1983-03-18
AT376674B (de) 1984-12-27
US4224329A (en) 1980-09-23
SU1168094A3 (ru) 1985-07-15
AU521986B2 (en) 1982-05-13
PL221248A1 (de) 1980-12-01
HU188201B (en) 1986-03-28
GB2041925A (en) 1980-09-17
FR2453174A1 (fr) 1980-10-31
JPS5636475A (en) 1981-04-09
GB2041925B (en) 1982-10-20
SE8404554L (sv) 1984-09-11
AR231291A1 (es) 1984-10-31
FR2453175B1 (de) 1983-07-29
FI800179A (fi) 1980-07-24
FR2453175A1 (fr) 1980-10-31
JPS5740151B2 (de) 1982-08-25
IN153300B (de) 1984-06-30
ATA33380A (de) 1984-05-15
FR2453174B1 (de) 1983-07-29
HU189174B (en) 1986-06-30
JPS5855151B2 (ja) 1983-12-08
CS221807B2 (en) 1983-04-29
HU184712B (en) 1984-10-29
IL59189A0 (en) 1980-05-30
KR830001932A (ko) 1983-05-19
CH648314A5 (fr) 1985-03-15
DD156369A5 (de) 1982-08-18
JPS55100386A (en) 1980-07-31
CS221806B2 (en) 1983-04-29
SE8000329L (sv) 1980-07-24
IE800121L (en) 1980-07-23
NL8000385A (nl) 1980-07-25
SE8404555D0 (sv) 1984-09-11
BE881283A (fr) 1980-07-22
PL126532B1 (en) 1983-08-31
NO151895C (no) 1985-06-26
JPS5636486A (en) 1981-04-09
PL126867B1 (en) 1983-09-30
YU242183A (en) 1984-06-30
NZ192175A (en) 1984-05-31
FR2447379B1 (de) 1983-08-19
NO843041L (no) 1980-07-24
PT70724A (en) 1980-02-01
PH17773A (en) 1984-12-11
SU1333239A3 (ru) 1987-08-23
DK25580A (da) 1980-07-24
DD149071A5 (de) 1981-06-24
PL120774B1 (en) 1982-03-31

Similar Documents

Publication Publication Date Title
SE441358B (sv) Sett att framstella 2-substituerad-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido-(4,3-b)indoler
BG61323B2 (bg) Производни на пиперидина,тяхното получаване и използването им като лекарства
US7923558B2 (en) Method for obtaining pure tetrahydrocannabinol
WO2004011463A1 (en) Modified pictet-spengler reaction and products prepared therefrom
FR2674849A1 (fr) Nouveaux derives de n-cyclohexyl benzamides ou thiobenzamides, leurs preparations et leurs applications en therapeutique.
US5831096A (en) L-tartaric acid salt of a (1R) diastereomer of a 2-azadihydroxybicyclo 2.2.1!heptane compound and the preparation of 2-azabicyclo 2.2.1! heptane compounds
WO2005080333A1 (en) Process for purification of ropinirole
LU85059A1 (fr) Composes amines heterocycliques et procedes pour leur preparation
US3557127A (en) Substituted cyclohexenes,derivatives thereof and processes for obtaining same
CA2093112A1 (fr) Derives spiraniques du 3-amino chromane, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
AU2001278094A1 (en) Novel crystalline forms of 4-[4-[4-(hydroxydiphenylmethyl)-1-piperindinyl]-1-hydroxybutyl]-alpha, alpha-dimethylbenzene acetic acid and its hydrochloride
WO2002102777A2 (en) NOVEL CRYSTALLINE FORMS OF 4-[4-[4-(HYDROXYDIPHENYLMETHYL)-1-PIPERINDINYL]-1-HYDROXYBUTYL]-α, α-DIMETHYLBENZENE ACETIC ACID AND ITS HYDROCHLORIDE
US6121280A (en) Azabicyclic rotomase inhibitors
JP4874122B2 (ja) トルテロジンを得るための方法
JP4056565B2 (ja) 炭素環式立体異性体混合物の分割方法
NO174669B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiopyranylaminer
US4927819A (en) Cyclo-octane neuroprotective agents
US3884976A (en) 7-Amino norbornane derivatives
US5670649A (en) Derivatives of 2-azabicyclo 2.2.1!heptane, their preparation and their application
JPH0550499B2 (de)
JP2003171354A (ja) 光学活性アミン化合物又はその塩の製造方法
WO2008137512A2 (en) Process for preparing pregabalin via hofmann reaction and crystalline form thereof
US3988362A (en) Intermediates for preparation of 2,2,3-endotrimethyl-7-anti-amino-norbornanes
CA1192189A (en) E-homo-eburnane derivatives and a process for preparing same
EP1000026A1 (de) Spezielle 3-azabicyclo 3.1.0]hexane, verfahren zu deren herstellung und modifizierung sowie deren verwendung